Est. 2019 · Pharmaceutical research, development, technology & contract services · Hyderabad, India sales@dgxpcompliancelab.com Careers

Capability

AI Across the Pharmaceutical Lifecycle

Practical AI where it helps pharmaceutical work — research, development, manufacturing, quality, regulatory, laboratory and supply chain — governed from day one.

Scientist reviewing a protein docking simulation on large monitors
Team collaborating in a computational research hub with data walls

What we do

AI earns its place in pharmaceutical work when it reduces review effort, surfaces patterns people miss, or makes knowledge easier to find — and when a qualified person still owns the decision.

We identify use cases, assess data readiness and risk, design the human-in-the-loop controls, and build or configure the solution with the validation evidence your quality unit needs.

Where it fits in the pharmaceutical lifecycle

Typical activities

Each activity shows who performs it. We do not claim facilities we do not own.

DGXP-led Led by the DGXPComplianceLab team Partner-coordinated Performed by a qualified partner, coordinated by us

  • Use-case discovery

    DGXP-led

    Workshops to find where AI adds measurable value.

  • Data readiness assessment

    DGXP-led

    Data sources, quality, access and integrity.

  • Solution design

    DGXP-led

    Model approach, retrieval design and human oversight.

  • Build and integration

    DGXP-led

    Assistants, analytics and document intelligence tools.

  • Validation

    DGXP-led

    Fit-for-intended-use testing and performance criteria.

  • Monitoring

    DGXP-led

    Performance, drift and change control after go-live.

AI across the pharmaceutical lifecycle

Select an area to see where AI can reasonably help today.

AI in research

  • Literature intelligence
  • Research knowledge discovery
  • Formulation research support

Every use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.

How we govern AI

From idea to governed AI

  1. 1Idea
  2. 2Use case
  3. 3Risk assessment
  4. 4Design
  5. 5Development
  6. 6Testing
  7. 7Validation
  8. 8Deployment
  9. 9Monitoring
  10. 10Change control

Technologies and processes

  • Large language models
  • Retrieval-augmented generation
  • Machine learning
  • Statistical process control
  • Document intelligence
  • Knowledge graphs

Our project execution model

Every engagement follows the same eight steps, scaled to the size and risk of the project.

  1. 01

    Understand

    Understand business and technical requirements.

  2. 02

    Assess

    Assess scientific, technical, regulatory and operational requirements.

  3. 03

    Design

    Design the appropriate solution.

  4. 04

    Identify

    Identify appropriate internal and external capabilities and partners.

  5. 05

    Execute

    Coordinate and execute the project.

  6. 06

    Verify

    Test, verify, qualify or validate where applicable.

  7. 07

    Document

    Create technical, quality and regulatory documentation.

  8. 08

    Improve

    Monitor, optimise and continuously improve.

Frequently asked questions

Can AI make GxP decisions?

In our approach AI assists; a qualified person reviews and decides. The level of oversight is set by risk assessment.

Does our data leave our control?

Deployment options and data flows are decided during design. Confidentiality and data-residency requirements are captured as requirements.

How do we know an AI tool is working correctly?

Through acceptance criteria defined before testing, validation against representative data, and ongoing performance monitoring.

Discuss a ai for pharma requirement

Share the product, stage and timeline. Capability is confirmed after technical assessment and partner availability.